Interstitial Cystitis / Painful Bladder Syndrome

Interstitial cystitis (IC), also called painful bladder syndrome (PBS), is a chronic condition characterized by persistent pelvic or suprapubic pain (>6 weeks) associated with intense urinary urgency and frequency, in the absence of urinary infection or other identifiable pathology. It predominantly affects women (90% of cases), with an estimated prevalence of 0.4%–2% of the adult population. Diagnosis is delayed (mean delay of 5–7 years) and the impact on quality of life is equivalent to that of conditions such as end-stage renal disease and severe rheumatoid arthritis.

5–7 years
MEAN DIAGNOSTIC DELAY
one of the most underdiagnosed conditions
90%
CASES IN WOMEN
F:M ratio of 9:1
60%
HAVE AN ASSOCIATED PELVIC CONDITION
vulvodynia, IBS, or fibromyalgia
Equivalent to ESRD
IMPACT ON QUALITY OF LIFE
according to health utility studies

The pathophysiology is multifactorial: deficiency of the urothelial glycosaminoglycan (GAG) layer (increases bladder permeability to irritating urinary substances); hyperactivated bladder mast cells (release histamine, tryptase, and NGF that sensitize suburothelial C fibers); and central sensitization (the CNS amplifies bladder impulses — dominant in the form without ulcer). Acupuncture acts especially on the immunological (mast cells) and neural (central and peripheral sensitization) components.

Conventional Treatments: A Difficult Condition to Treat

No available treatment is universally effective for IC. The approach is escalated and multimodal — starting with the least invasive measures. Acupuncture fits in as a second-line treatment before invasive interventions.

TREATMENTS FOR INTERSTITIAL CYSTITIS (BY LEVEL OF INVASIVENESS)

TREATMENTEFFICACYLIMITATIONS
Diet and lifestyle modification20%–30% reduction in symptoms in 50% of patientsExtremely restrictive; not sufficient alone in most cases
Pentosan polysulfate (PPS 100 mg 3x/day)Response in 30%–40% after 6 monthsSlow response; pigmentary maculopathy with prolonged use — serious adverse effect; cost
Amitriptyline 10–75 mg/dayResponse in 40%–50%; better profile than PPSDrowsiness, weight gain; not specifically approved for IC in Brazil
Bladder instillation (DMSO, heparin, lidocaine)Immediate response in 40%–60% of casesInvasive procedure (catheterization); discomfort; cost; specialized resource
Cystoscopic hydrodistensionTransient improvement in 30%–50%; diagnostic and therapeuticGeneral anesthesia or sedation; risk of perforation; benefit limited to 6 months
AcupunctureICSI reduction reported in small studies; anti-inflammatory signaling described in case series with biopsyEvidence still limited; does not replace indicated pharmacological therapy; variable access

How Acupuncture Works in Interstitial Cystitis

Mechanisms in Interstitial Cystitis

  1. Reduction of Bladder Mast Cell Activation

    ST-36 and SP-6 reduce the degranulation of bladder mast cells — documented in follow-up biopsies of acupuncture studies for IC. Histamine and tryptase released by mast cells sensitize suburothelial C fibers; reducing mast cell activation breaks this inflammatory cycle.

  2. Neuromodulation of Bladder C Fibers

    BL-32+BL-33 (sacral foramina S2–S3) modulate the hypersensitized suburothelial C fibers — the main afferent pathway of pain in IC. EA at 2 Hz reduces the ectopic discharge of C fibers and progressively normalizes the bladder pain threshold.

  3. Reduction of Central Sensitization

    In IC without Hunner ulcer, central sensitization is dominant: the L1–S3 dorsal horn amplifies all bladder stimuli. Acupuncture reduces the expression of c-fos and NMDA-R in the dorsal horn — progressively desensitizing the central pain system that perpetuates symptoms even without active peripheral lesion.

  4. Improvement of Bladder Epithelium via Parasympathetic Tone

    CV-3 and KI-3 activate the S2–S4 parasympathetic, which improves bladder submucosal vascular flow. Better-perfused epithelium produces more glycosaminoglycans (GAG) — the protective component of the defective urothelial layer in IC. A slow but potentially modifying trophic effect on the urothelial barrier.

Main Points

BL32BL33 — Sacral Bladder Neuromodulation

Sacral foramina S2S3: access point to the pelvic nerve roots. EA at 2 Hz — same mechanism as implantable sacral neuromodulation, in a non-invasive way. Central point in the IC protocol.

CV3 — Front-Mu of the Bladder

Bladder alarm point in Chinese medicine. Located on the midline 2 cun above the pubic symphysis. Modulates bladder autonomic innervation and is the local point par excellence for IC and OAB.

SP6 — PTNS and Bladder Antispasmodic

Neuromodulation of the posterior tibial nerve — same mechanism as PTNS (AUA-approved). In IC, reduces frequency and urgency and complements the sacral effect of BL32BL33.

ST36 — Anti-inflammatory and Mast Cells

ST36 reduces mast cell degranulation via vagus nerve activation (cholinergic anti-inflammatory reflex). Documented in IC biopsies post-acupuncture as objective reduction of mast cell density.

Scientific Evidence

Modern Approach: Position of Acupuncture in the IC Algorithm

IC with Predominant Central Sensitization

IC without Hunner ulcer, with overlap of vulvodynia, IBS, or fibromyalgia: acupuncture is the most efficient approach — acts on the central mechanism common to all conditions. Combined protocols BL32+CV3+SP6+ST36 with EA.

Complementary Option with Favorable Safety Profile

Reports of pigmentary maculopathy associated with prolonged use of PPS reinforce the importance of individualized discussion with the urologist. Acupuncture, with no systemic toxicity described, can be useful as a complementary option — the decision to maintain, reduce, or substitute any drug always rests with the attending physician.

When to See a Medical Acupuncturist

Indications

IC with diagnosis confirmed by urologist; failure or intolerance of PPS; IC associated with vulvodynia or IBS (central sensitization syndrome); as alternative to PPS in the long term; complement to bladder instillations.

Integration with Urology

Diagnosis of IC requires cystoscopy to exclude Hunner ulcer, tumor, and lithiasis. The medical acupuncturist must have the diagnosis established by the urologist before starting. Parallel treatments (instillations, PPS) are compatible with acupuncture.

Frequently Asked Questions

FREQUENTLY ASKED QUESTIONS · 04

Frequently Asked Questions

There is no known cure for IC. Acupuncture — like all available treatments — controls symptoms, not the underlying disease. The goal is to reduce pain, urgency, and frequency to levels that allow a satisfactory quality of life. Acupuncture can maintain control with periodic maintenance sessions — without the long-term adverse effects of PPS.

Not necessarily — they are compatible treatments. If PPS is partially controlling symptoms and the physician indicated its continuation, it can be maintained during acupuncture treatment. The decision to reduce or discontinue PPS should be evaluated jointly by the urologist, especially considering the risk of retinal maculopathy with prolonged use.

Yes — and this is one of the most compelling cases for acupuncture. IC and IBS frequently coexist because they share the same underlying mechanism: central sensitization of visceral afferent pathways. The acupuncture protocol for IC (BL-32+CV-3+SP-6+ST-36) includes points (ST-25+ST-36) that also address IBS — treating both conditions through the common central mechanism.

Yes. Acupuncture can be started 1–2 weeks after cystoscopic hydrodistension, when the acute post-procedure symptoms have stabilized. Many specialists use the combination: hydrodistension for initial acute control + acupuncture for long-term maintenance — taking advantage of the strengths of each approach.

Related Articles